Why ASLAN Pharmaceuticals Blasted Higher on Friday
Shareholders of ASLAN Pharmaceuticals (NASDAQ: ASLN) are primed for a good weekend. Raycroft believes the shares are worth $8 apiece, more than 150% higher than Thursday's closing price. ASLAN, a clinical-stage immunology biotech, only has two treatments in development.